iPS Cell Regenerative Medicine to Rely on Donor Cells in Order to Cut 77% of Costs
From this autumn Kyoto University’s iPS Research Institute will start to supply iPS (induced pluripotent stem) cells for regenerative medicine to ten research labs and pharmaceutical companies. The special feature of these cells is that they are derived from blood cell type that matches about 20% of Japanese population and […]